Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,675.00p
   
  • Change Today:
      35.00p
  • 52 Week High: 2,450.00
  • 52 Week Low: 1,366.67
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 12,310
  • Market Cap: £87.52m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
38.06% below the market average38.06% below the market average38.06% below the market average38.06% below the market average38.06% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
1yr Revenue Growth
42.1% below the market average42.1% below the market average42.1% below the market average42.1% below the market average42.1% below the market average
44% below the sector average44% below the sector average44% below the sector average44% below the sector average44% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
86.77% above the market average86.77% above the market average86.77% above the market average86.77% above the market average86.77% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
61.18% below the market average61.18% below the market average61.18% below the market average61.18% below the market average61.18% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
31.76% above the market average31.76% above the market average31.76% above the market average31.76% above the market average31.76% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Price Book Ratio
82.7% below the market average82.7% below the market average82.7% below the market average82.7% below the market average82.7% below the market average
53.33% below the sector average53.33% below the sector average53.33% below the sector average53.33% below the sector average53.33% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
88.8% below the market average88.8% below the market average88.8% below the market average88.8% below the market average88.8% below the market average
67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average
Price Chg 3m
81.34% below the market average81.34% below the market average81.34% below the market average81.34% below the market average81.34% below the market average
67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
71.03% above the market average71.03% above the market average71.03% above the market average71.03% above the market average71.03% above the market average
92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average
ROCE
79.10% above the market average79.10% above the market average79.10% above the market average79.10% above the market average79.10% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
87.52% above the market average87.52% above the market average87.52% above the market average87.52% above the market average87.52% above the market average
84.21% above the sector average84.21% above the sector average84.21% above the sector average84.21% above the sector average84.21% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
36.66% below the market average36.66% below the market average36.66% below the market average36.66% below the market average36.66% below the market average
15.38% above the sector average15.38% above the sector average15.38% above the sector average15.38% above the sector average15.38% above the sector average
Operating Profit Loss
20.98% above the market average20.98% above the market average20.98% above the market average20.98% above the market average20.98% above the market average
68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
26.35% below the market average26.35% below the market average26.35% below the market average26.35% below the market average26.35% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Cash
22.9% below the market average22.9% below the market average22.9% below the market average22.9% below the market average22.9% below the market average
21.05% above the sector average21.05% above the sector average21.05% above the sector average21.05% above the sector average21.05% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
13.68% above the market average13.68% above the market average13.68% above the market average13.68% above the market average13.68% above the market average
4.76% below the sector average4.76% below the sector average4.76% below the sector average4.76% below the sector average4.76% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,675.00p
Change Today 35.00p
% Change 2.13 %
52 Week High 2,450.00
52 Week Low 1,366.67
Volume 12,310
Shares Issued 5.22m
Market Cap £87.52m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.08% above the market average28.08% above the market average28.08% above the market average28.08% above the market average28.08% above the market average
42.11% above the sector average42.11% above the sector average42.11% above the sector average42.11% above the sector average42.11% above the sector average
Price Trend
91.85% below the market average91.85% below the market average91.85% below the market average91.85% below the market average91.85% below the market average
67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average
Income Not Available
Growth
63.29% below the market average63.29% below the market average63.29% below the market average63.29% below the market average63.29% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Bioventix Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 09-Apr-26 06-Nov-25
Paid 24-Apr-26 21-Nov-25
Amount 70.00p 80.00p

Trades for 02-Oct-2026

Time Volume / Share Price
16:06 650 @ 1,655.00p
15:57 80 @ 1,690.00p
15:47 500 @ 1,692.50p
15:40 81 @ 1,655.00p
15:09 600 @ 1,694.50p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page